肿瘤学：Colorectal cancers with distinct metastatic potential trigger divergent early T cell responses.

原文摘录：Colorectal cancer (CRC) remains a leading cause of mortality, with most cases refractory to immunotherapy. Distinguishing tumor-induced from steady-state mucosal T cell responses represents a critical barrier to understanding CRC immunity.